Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cancer of Oropharnyx

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Cancer of Oropharnyx in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, AK1
McKenna, WG1
Weber, CN1
Feldman, MD1
Goldsmith, JD1
Mick, R1
Machtay, M1
Rosenthal, DI1
Bakanauskas, VJ1
Cerniglia, GJ1
Bernhard, EJ1
Weber, RS1
Muschel, RJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase III Randomized Clinical Trial to Study the Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Uterine Cervix.[NCT03256916]Phase 3348 participants (Anticipated)Interventional2018-01-16Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cancer of Oropharnyx

ArticleYear
Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Chromone

2002